title: Strength capacity in young patients who are receiving maintenance therapy for acute lymphoblastic leukemia: a case-control study.
authors.affiliation: Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil.
authors.forename: Mavi Diehl
authors.initials: MD
authors.lastname: Muratt
authors.forename: Maria Beatriz
authors.initials: MB
authors.lastname: Perondi
authors.forename: Julia Maria D'Andréa
authors.initials: JM
authors.lastname: Greve
authors.forename: Hamilton
authors.initials: H
authors.lastname: Roschel
authors.forename: Ana Lúcia de Sá
authors.initials: AL
authors.lastname: Pinto
authors.forename: Bruno
authors.initials: B
authors.lastname: Gualano
mesh_terms: D000293:Adolescent; D000367:Age Factors; D000970:Antineoplastic Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D002648:Child; D003907:Dexamethasone / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D053580:Muscle Strength / Q000187:drug effects*; D052580:Muscle Stretching Exercises; D018908:Muscle Weakness / Q000209:etiology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors; D014750:Vincristine / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D014750:Vincristine; D003907:Dexamethasone; D015122:Mercaptopurine; D008727:Methotrexate